Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(8/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(8/week)
News
United States
(492/week)
Manufacturing
(332/week)
Energy
(271/week)
Technology
(348/week)
Other Energy
(234/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Donepezil
Apr 21, 2020
Linical and Alpha Cognition Announce Strategic Partnership to Position Alpha-1062 for Approval in the United States and Japan Alzheimer's Markets
Dec 17, 2019
BioArctic Announces Research Collaboration with Eisai Regarding BAN2401
Dec 05, 2019
BioArctic's Partner Eisai Presents Data from the Ongoing BAN2401 Phase 2b Extension Study in Early Alzheimer's Disease
Dec 02, 2019
BioArctic and Eisai to Present Data on BAN2401 at the Clinical Trials on Alzheimer's Disease Conference
Nov 28, 2019
Analysis on the World Alzheimer's Therapeutics Market 2019-2025 - Eisai Co, Novartis, Pfizer, Eli Lilly & Company, and Johnson & Johnson are Dominating
Sep 13, 2019
Eisai And Biogen To Discontinue Phase III Clinical Studies Of BACE Inhibitor Elenbecestat In Early Alzheimer's Disease
May 20, 2019
BioArctic Receives MEUR 15 Milestone Payment from Eisai for Start of BAN2401 Confirmatory Phase 3 Study in Early Alzheimer's Disease
May 10, 2019
BioArctic: Alzheimer's Clinical Trials Consortium and Eisai Announce BAN2401 to be Evaluated in Clinical Study for Prevention of Alzheimer's Disease
Mar 21, 2019
BioArctic's Partner Eisai Initiates the Confirmatory Phase 3 Study of BAN2401 in Early Alzheimer's Disease
Mar 07, 2019
BioArctic: Eisai Announces Timelines for the Single Confirmatory Phase 3 Study With BAN2401 in Warly Alzheimer's Disease
Oct 25, 2018
BioArctic Announces Additional BAN2401 Phase 2b Study Results in Early Alzheimer's Disease Presented by Eisai at the 2018 CTAD Conference
Jul 25, 2018
BioArctic Announces Detailed Results of the BAN2401 Phase 2b Study in Early Alzheimer's Disease Presented at AAIC 2018
Jul 25, 2018
Eisai And Biogen Announce Detailed Results Of Phase II Clinical Study Of BAN2401 In Early Alzheimer's Disease At Alzheimer's Association International Conference (AAIC) 2018
Jul 25, 2018
Eisai And Biogen Present Detailed Results From Phase II Clinical Study Of Elenbecestat In MCI And Mild To Moderate Alzheimer's Disease At Alzheimer's Association International Conference (AAIC) 2018
Jul 18, 2018
BioArctic: Late Breaking Phase 2b Study Results of BAN2401 in Alzheimer's Disease Will be Webcast Live From AAIC 2018 by Eisai
Jul 09, 2018
BioArctic Announces Acceptance of BAN2401 Phase 2b Results for Oral Presentation at the AAIC 2018
Jul 09, 2018
Eisai Announces Acceptance of BAN2401 Phase II Results for Oral Presentation at the 2018 Alzheimer's Association International Conference (AAIC)
Jul 05, 2018
Eisai And Biogen Announce Positive Topline Results Of The Final Analysis For BAN2401 At 18 Months
Jul 05, 2018
BioArctic Announces Positive Topline Results of BAN2401 Phase 2b at 18 Months in Early Alzheimer's Disease
Jun 12, 2018
Eisai Inc. to Launch Center for Genetics Guided Dementia Discovery in Cambridge, Massachusetts
Page 1
››
Latest News
Apr 19, 2024
Small Wind Global Strategic Industry Report 2024-2030: Small Wind Turbines - A Real Blue-Sky Opportunity for...
Apr 19, 2024
Essential Utilities Names Natalie Chesko as New President of Aqua New Jersey
Apr 18, 2024
Black Bear Transmission Places Ozark Supply Access Project In-Service
Apr 18, 2024
NGS Simulates First-Ever Performance Demonstration of New Glazing Security Solution, 3M S2400
Apr 18, 2024
CLEAResult Releases 2023 Sustainability Report, Showcasing 133 Million Metric Tons of CO2 Averted Since 2003
Apr 18, 2024
TriMas Packaging Group to Exhibit at LUXE PACK New York and China Beauty Expo
Apr 18, 2024
Zero Motorcycles Launches Tesla Tap Mini: The Key to Expanded Charging Options
Apr 18, 2024
Ferguson plc: Publication of Registration Statement, Proxy Statement, Notice of Special Meeting and U.K....
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events